Full
Outline
To evaluate the effectiveness of hepatitis B vaccination in Fenghua district, Ningbo city from 1992 to 2020.
The epidemiological survey data on hepatitis B serology in Fenghua district in 1992 and 2020 were collected for comparison of the positive rates of hepatitis B surface antigen (HBsAg) and hepatitis B surface antibody (anti-HBs). Furthermore, data on the incidence of hepatitis B from 1992 to 2020 were collected for comparison of the average annual incidence of hepatitis B during the planned immunization management stage (1992–2001), the immunization planning management stage (2002–2011), and the implementation stage of the hepatitis B mother-to-child transmission prevention strategy (2012–2020). The decision tree-Markov model was adopted to evaluate the effectiveness of hepatitis B vaccination in newborns from 1992 to 2020.
The positive rate of HBsAg across the entire population declined from 13.79% in 1992 to 5.42% in 2020 (χ2 = 31.73, P < 0.01), with all age groups within the cohort of 0–24 years old experiencing a reduction to 0%. The positive rate of anti-HBs in the age group of 0–4 years old increased from 34.48% in 1992 to 90.16% in 2020 (χ2 = 30.38, P < 0.01). The incidence of hepatitis B significantly decreased among individuals aged 0–29 years old. Particularly, the age groups of 0–4, 5–9, and 10–14 years old during 2012–2020 showed declines of 86.08%, 94.63%, and 94.55% respectively, compared with those in 1992–2001. According to the decision tree-Markov model, compared with those who did not receive hepatitis B vaccination, the vaccination among 114 670 individuals in Fenghua district from 1992 to 2020 prevented 6 894 cases of acute hepatitis B, 30 832 cases of hepatitis B carriers, 4 705 cases of chronic hepatitis B, 4 043 cases of liver cirrhosis, 3 265 cases of liver cancer, and 4 411 hepatitis B-related deaths.
The hepatitis B vaccination program in Fenghua district has yielded remarkable results, significantly decreasing both the positive rate of HBsAg and the incidence of hepatitis B among young age groups. It is imperative to continue enhancing the hepatitis B vaccination efforts for newborns.
58
21
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |
关闭全屏
No. 86 Xueyuan South Road, Haidian District, Beijing
010-62662699(Operation and Technical Support)
qkjq@cast.org.cn
Copyright © 2025 China Association for Science and Technology. All rights reserved. For all open access content, the relevant licensing terms apply.
Sponsored by the Office of the Leading Group for Cybersecurity and Informatization of CAST, and supported by Science and Technology Review Publishing House
